首页 > 最新文献

The gulf journal of oncology最新文献

英文 中文
Transoral Surgical Excision Of A Parapharyngeal Space Tumour: Case Report And Literature Review. 经口手术切除咽旁间隙肿瘤1例报告及文献复习。
Q3 Medicine Pub Date : 2021-09-01
Nik Mohd Syahrul Hafizzi Awang, Ali Haron, Baharudin Abdullah

Background: The parapharyngeal tumour is a rare case of head and neck tumour. Benign and malignant tumours can arise from any of the structures contained within the parapharyngeal space. Pleomorphic adenoma is the most typical salivary gland tumour that is found in this space and surgical resection is the main treatment for this tumour. Since the modern era of the medicine, different kinds of diagnostic imaging and surgical approaches have been introduced to evaluate this tumour.

Case presentation: We present a case report of a parapharyngeal space mass that was found to be pleomorphic adenoma of minor salivary gland, their clinical presentation, radiological imaging and literature review of the transoral surgical approaches for parapharyngeal tumour.

Discussion and conclusion: The transoral approach remains one of the classical and effective methods for the resection of the benign prestyloid parapharyngeal tumour. The surgeons need to have a good knowledge of diagnostic imaging and surgical techniques to determine which surgical procedure is the best for the patients in order to eradicate the diseases and minimize the complications ultimately.

背景:咽旁肿瘤是一种罕见的头颈部肿瘤。良性和恶性肿瘤可产生于咽旁间隙内的任何结构。多形性腺瘤是唾液腺中最典型的肿瘤,手术切除是该肿瘤的主要治疗方法。自现代医学以来,不同种类的诊断成像和手术方法已被引入来评估这种肿瘤。病例报告:我们报告一例咽旁间隙肿块,发现为小唾液腺多形性腺瘤,其临床表现,影像学和经口手术入路咽旁肿瘤的文献回顾。讨论与结论:经口入路是切除良性茎突前突咽旁肿瘤的经典而有效的方法之一。外科医生需要对诊断成像和手术技术有很好的了解,以确定哪种手术方法对患者最好,从而最终根除疾病并减少并发症。
{"title":"Transoral Surgical Excision Of A Parapharyngeal Space Tumour: Case Report And Literature Review.","authors":"Nik Mohd Syahrul Hafizzi Awang,&nbsp;Ali Haron,&nbsp;Baharudin Abdullah","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The parapharyngeal tumour is a rare case of head and neck tumour. Benign and malignant tumours can arise from any of the structures contained within the parapharyngeal space. Pleomorphic adenoma is the most typical salivary gland tumour that is found in this space and surgical resection is the main treatment for this tumour. Since the modern era of the medicine, different kinds of diagnostic imaging and surgical approaches have been introduced to evaluate this tumour.</p><p><strong>Case presentation: </strong>We present a case report of a parapharyngeal space mass that was found to be pleomorphic adenoma of minor salivary gland, their clinical presentation, radiological imaging and literature review of the transoral surgical approaches for parapharyngeal tumour.</p><p><strong>Discussion and conclusion: </strong>The transoral approach remains one of the classical and effective methods for the resection of the benign prestyloid parapharyngeal tumour. The surgeons need to have a good knowledge of diagnostic imaging and surgical techniques to determine which surgical procedure is the best for the patients in order to eradicate the diseases and minimize the complications ultimately.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"85-90"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Study Of Concurrent Chemo-Radiotherapy With or Without Neoadjuvant Chemotherapy in Treatment of Locally Advanced Non Small Cell Lung Cancer. 同步放化疗加与不加新辅助化疗治疗局部晚期非小细胞肺癌的比较研究。
Q3 Medicine Pub Date : 2021-09-01
Simrandeep Singh, Ratika Gupta, Tejinder Paul Singh, S L Jakhar, Neeti Sharma, H S Kumar

Introduction: The standard treatment for unresectable stage III non-small-cell lung cancer (NSCLC) is concurrent chemoradiotherapy. This study was undertaken to evaluate whether induction chemotherapy along with concurrent chemoradiotherapy would result in better tumor control, improved symptom control and any variation in toxicity as compared to concurrent chemoradiotherapy alone.

Patients and methods: Between February 2015 to September 2016, 25 patients each were randomized to control group, in which they received concurrent chemoradiotherapy with weekly cisplatin 40 mg/m2 intravenous, during chest radiotherapy of 66Gy in 33 fractions for 6.5 weeks, and study group, in which patients received three cycles of induction chemotherapy with Cisplatin 75 mg/m2and Paclitaxel 175 mg/m2administered every 21 days followed by identical chemoradiotherapy.

Results: The two groups of patients (with induction vs. without induction chemotherapy) were similar in age, performance status, histology, grade, and stage. At 6thmonth follow-up, complete response was seen in 6 patients in control arm and 7 patients in study arm (?2 = 1.603, p = 0.205) and partial response was seen in 13 and 12 patients in control and study arms respectively (?2 = 1.932, p = 0.165). Symptom control of cough, hemoptysis, chest pain and dyspnoea were also similar in both groups.

Discussion: In our study, no difference in treatment outcome with respect to the two groups was observed, which was similar to studies which have been conducted previously. Radiation is a good modality for symptom control of cough, hemoptysis, chest pain and dyspnoea. In toxicities, pneumonitis and hematological toxicity was slightly higher in study group even at 6th month follow up.

Conclusion: Slight increase in toxicity with no added benefit in locoregional tumor control and symptom regression, was seen in patients receiving induction chemotherapy followed by chemoradiotherapy. Concurrent chemoradiotherapy alone can thus be used as only modality of treatment in unresectable stage III NSCLC.

不可切除的III期非小细胞肺癌(NSCLC)的标准治疗是同步放化疗。本研究旨在评估诱导化疗联合同步放化疗与单独同步放化疗相比,是否能更好地控制肿瘤,改善症状控制和毒性变化。患者及方法:2015年2月至2016年9月,随机选取25例患者,对照组患者接受顺铂40mg /m2静脉同步放化疗,66Gy分33次胸腔放疗,疗程6.5周;研究组患者接受顺铂75mg /m2、紫杉醇175mg /m2诱导化疗,每21天给药3个周期,同时进行相同的放化疗。结果:两组患者(诱导与不诱导化疗)在年龄、运动状态、组织学、分级和分期上相似。在6个月的随访中,对照组有6例患者完全缓解,研究组有7例患者完全缓解。2 = 1.603, p = 0.205),对照组和研究组分别有13例和12例患者出现部分缓解(?2 = 1.932, p = 0.165)。两组咳嗽、咯血、胸痛、呼吸困难的症状控制情况相似。讨论:在我们的研究中,没有观察到两组治疗结果的差异,这与之前的研究相似。放射治疗是控制咳嗽、咯血、胸痛、呼吸困难等症状的良好方法。在毒性方面,即使在随访6个月时,研究组的肺炎和血液毒性也略高。结论:在诱导化疗后放化疗的患者中,毒性略有增加,但在局部肿瘤控制和症状消退方面没有增加益处。因此,同步放化疗可以作为无法切除的III期非小细胞肺癌的唯一治疗方式。
{"title":"A Comparative Study Of Concurrent Chemo-Radiotherapy With or Without Neoadjuvant Chemotherapy in Treatment of Locally Advanced Non Small Cell Lung Cancer.","authors":"Simrandeep Singh,&nbsp;Ratika Gupta,&nbsp;Tejinder Paul Singh,&nbsp;S L Jakhar,&nbsp;Neeti Sharma,&nbsp;H S Kumar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The standard treatment for unresectable stage III non-small-cell lung cancer (NSCLC) is concurrent chemoradiotherapy. This study was undertaken to evaluate whether induction chemotherapy along with concurrent chemoradiotherapy would result in better tumor control, improved symptom control and any variation in toxicity as compared to concurrent chemoradiotherapy alone.</p><p><strong>Patients and methods: </strong>Between February 2015 to September 2016, 25 patients each were randomized to control group, in which they received concurrent chemoradiotherapy with weekly cisplatin 40 mg/m2 intravenous, during chest radiotherapy of 66Gy in 33 fractions for 6.5 weeks, and study group, in which patients received three cycles of induction chemotherapy with Cisplatin 75 mg/m2and Paclitaxel 175 mg/m2administered every 21 days followed by identical chemoradiotherapy.</p><p><strong>Results: </strong>The two groups of patients (with induction vs. without induction chemotherapy) were similar in age, performance status, histology, grade, and stage. At 6thmonth follow-up, complete response was seen in 6 patients in control arm and 7 patients in study arm (?2 = 1.603, p = 0.205) and partial response was seen in 13 and 12 patients in control and study arms respectively (?2 = 1.932, p = 0.165). Symptom control of cough, hemoptysis, chest pain and dyspnoea were also similar in both groups.</p><p><strong>Discussion: </strong>In our study, no difference in treatment outcome with respect to the two groups was observed, which was similar to studies which have been conducted previously. Radiation is a good modality for symptom control of cough, hemoptysis, chest pain and dyspnoea. In toxicities, pneumonitis and hematological toxicity was slightly higher in study group even at 6th month follow up.</p><p><strong>Conclusion: </strong>Slight increase in toxicity with no added benefit in locoregional tumor control and symptom regression, was seen in patients receiving induction chemotherapy followed by chemoradiotherapy. Concurrent chemoradiotherapy alone can thus be used as only modality of treatment in unresectable stage III NSCLC.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"62-69"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prognostic Value Of The ART Score Before The Second Transarterial Chemoembolization. 第二次经动脉化疗栓塞前ART评分的预后价值。
Q3 Medicine Pub Date : 2021-09-01
Fatima Zahra Hamdoun, Younes Hassani, Hakima Abid, Youssef Lamrani Alaoui, Mounia El Yousfi, Dafr-Allah Benajah, Moustapha Maaroufi, Mohammed ElAbkari, SidiAdil Ibrahimi, Nada Lahmidani

The transarterial chemoembolization (TACE) is a firstline therapeutic option for advanced hepatocellular carcinoma (HCC). Their indications are clearly defined by learned societies but the challenge is to determine the optimal number of TACE sessions that will benefit patients before switching to other therapies. For this reason, the Assessment for Retreatment with Transarterial chemoembolization (ART) score has been developed. The objective of our work is to show the prognostic value of the ART score before the second TACE.

Methods: This is a retrospective and prospective study of patients with hepatocellular carcinoma on cirrhosis liver who received a TACE between January 2012 to July 2019. The diagnosis of HCC was made according to the non-invasive criteria of EASL with the use of histology for doubtful cases. The ART score was calculated after the first chemoembolization. Patients were divided into 2groups: group A with an ART score between 0 and 1.5 and group B with a score =2.5.

Results: During the study period, 58 patients with HCC on cirrhosis liver received a TACE: 55.17% had an ART score between 0 - 1.5 before the second session and 44.8% had an ART score =2,5. Both groups were comparable regarding age, circumstances of discovery and Child's score. The size of the HCC as well as the value of the AFP was further increased in the group B. We observed a significant difference in the radiological response, the Child score and aspartate transaminase rate between the two groups after the first TACE. The overall survival rate at 3 years was 81% in group A versus 19% in group B.

Conclusion: The ART score has an independent prognostic value and should be taken into account in the therapeutic strategy before the second TACE.

经动脉化疗栓塞(TACE)是晚期肝细胞癌(HCC)的一线治疗选择。它们的适应症已被学术团体明确定义,但挑战在于确定TACE治疗的最佳次数,这将使患者在转向其他治疗之前受益。因此,经动脉化疗栓塞再治疗评估(ART)评分被开发出来。我们工作的目的是显示ART评分在第二次TACE前的预后价值。方法:这是一项回顾性和前瞻性研究,研究对象是2012年1月至2019年7月期间接受TACE治疗的肝硬化肝细胞癌患者。根据EASL的无创标准诊断HCC,对可疑病例使用组织学。第一次化疗栓塞后计算ART评分。患者分为2组:A组ART评分0 ~ 1.5分,B组ART评分2.5分。结果:在研究期间,58例肝硬化HCC患者接受了TACE治疗:55.17%的患者在第二次治疗前ART评分在0 - 1.5之间,44.8%的患者ART评分为2,5。两组在年龄、发现情况和儿童评分方面具有可比性。b组肝细胞癌的大小和AFP值进一步增加,我们观察到两组在第一次TACE后的放射学反应、Child评分和天冬氨酸转氨酶率有显著差异。A组3年总生存率为81%,b组为19%。结论:ART评分具有独立的预后价值,在第二次TACE治疗前的治疗策略中应予以考虑。
{"title":"The Prognostic Value Of The ART Score Before The Second Transarterial Chemoembolization.","authors":"Fatima Zahra Hamdoun,&nbsp;Younes Hassani,&nbsp;Hakima Abid,&nbsp;Youssef Lamrani Alaoui,&nbsp;Mounia El Yousfi,&nbsp;Dafr-Allah Benajah,&nbsp;Moustapha Maaroufi,&nbsp;Mohammed ElAbkari,&nbsp;SidiAdil Ibrahimi,&nbsp;Nada Lahmidani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The transarterial chemoembolization (TACE) is a firstline therapeutic option for advanced hepatocellular carcinoma (HCC). Their indications are clearly defined by learned societies but the challenge is to determine the optimal number of TACE sessions that will benefit patients before switching to other therapies. For this reason, the Assessment for Retreatment with Transarterial chemoembolization (ART) score has been developed. The objective of our work is to show the prognostic value of the ART score before the second TACE.</p><p><strong>Methods: </strong>This is a retrospective and prospective study of patients with hepatocellular carcinoma on cirrhosis liver who received a TACE between January 2012 to July 2019. The diagnosis of HCC was made according to the non-invasive criteria of EASL with the use of histology for doubtful cases. The ART score was calculated after the first chemoembolization. Patients were divided into 2groups: group A with an ART score between 0 and 1.5 and group B with a score =2.5.</p><p><strong>Results: </strong>During the study period, 58 patients with HCC on cirrhosis liver received a TACE: 55.17% had an ART score between 0 - 1.5 before the second session and 44.8% had an ART score =2,5. Both groups were comparable regarding age, circumstances of discovery and Child's score. The size of the HCC as well as the value of the AFP was further increased in the group B. We observed a significant difference in the radiological response, the Child score and aspartate transaminase rate between the two groups after the first TACE. The overall survival rate at 3 years was 81% in group A versus 19% in group B.</p><p><strong>Conclusion: </strong>The ART score has an independent prognostic value and should be taken into account in the therapeutic strategy before the second TACE.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39912925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation Of Pathological Response And Its Predictors In Carcinoma Rectum Following Neoadjuvant Chemoradiation. 直肠癌新辅助放化疗后病理反应的评价及其预测因素。
Q3 Medicine Pub Date : 2021-09-01
Shoaib Nawaz, Sangeetha K Nayanar, Nabeel Yahiya

Background: Neoadjuvant chemoradiation followed by surgery is the standard of care in locally advanced rectal tumors. Better pathologic response after chemoradiation is associated with better outcomes. Pathologic response may depend on various, patient and tumor related factors. The aim of our study was to assess the pathological response using a modified Ryan scoring system and to study various factors which influence the response.

Materials and methods: This is a retrospective study carried out at a tertiary cancer centre in India. Patient details and histopathology reports of rectal cancer patients who took neoadjuvant chemoradiation from January 2016 to December 2018 were analyzed. Demographic details, pathological response assessed by modified Ryans tumor regression grade (TRG) score and various factors which influence the pathological response were studied. Those with TRG score 0 (complete response) and1(near complete response) were grouped together as good responders and those with score 3 (partial response) and 4 (poor or no response) as poor responders. Univariate and multivariate analyses were performed using logistic regression to determine factors which influence pathologic response.

Results: There were a total of 83 patients. Males and females were equally distributed. 43.4%(n=36) of patients had lower rectal tumors,32.5%(n=27) had midrectal tumors and 24.1%(n=20) had upper rectal tumors. 46% of patients were good responders which includes complete responders ,17% (n=14) and those with a near complete response,29% (n=24). 54% of patients were poor responders,which includes those with incomplete response,36% (n=34) and with no or poor response,18% (n=15). Among the upper rectal tumors, only 20% had good response and among the mid and lower rectal tumors 54% had good response.(p value 0.02).63% of males were good responders in comparison to 37% among females (p value 0.05).

Discussion: Response to neoadjuvant chemoradiation with capecitabine in locally advanced rectal tumors in our institute is similar to the literature data with a complete response in 16.9%, near complete response in 28.9% partial response in 36.1% and no response in 18.1% of patients, according to modified Ryan score. It was found that upper rectal tumors had a poorer response when compared to mid and lower tumors and females had a poorer response compared to males.

Conclusion: Even though neoadjuvant chemoradiation remains the standard of care in locally advanced rectal carcinomas, its benefit in upper rectal tumors needs to be validated in larger studies.

背景:手术后的新辅助放化疗是局部晚期直肠肿瘤的标准治疗方法。放化疗后较好的病理反应与较好的预后相关。病理反应可能取决于各种患者和肿瘤相关因素。本研究的目的是使用改进的Ryan评分系统来评估病理反应,并研究影响反应的各种因素。材料和方法:这是一项在印度三级癌症中心进行的回顾性研究。分析2016年1月至2018年12月接受新辅助放化疗的直肠癌患者的患者资料和组织病理学报告。研究患者的人口学资料、改良ryan肿瘤消退分级(TRG)评价的病理反应及影响病理反应的各种因素。TRG评分为0分(完全缓解)和1分(接近完全缓解)的患者归为良好反应者,评分为3分(部分缓解)和4分(不良或无反应)的患者归为不良反应者。采用logistic回归进行单因素和多因素分析,以确定影响病理反应的因素。结果:共83例患者。男性和女性平均分布。下直肠肿瘤占43.4%(n=36),中直肠肿瘤占32.5%(n=27),上直肠肿瘤占24.1%(n=20)。46%的患者是良好应答者,其中包括完全应答者,17% (n=14)和接近完全应答者,29% (n=24)。54%的患者为不良反应,其中不完全反应占36% (n=34),无反应或不良反应占18% (n=15)。在直肠上部肿瘤中,只有20%的肿瘤有良好的反应,而在直肠中下部肿瘤中,有54%的肿瘤有良好的反应。(p值0.02)。63%的男性反应良好,而女性反应良好的比例为37% (p值0.05)。讨论:根据改进的Ryan评分,我院局部进展期直肠肿瘤卡培他滨新辅助放化疗的反应与文献数据相似,16.9%的患者完全缓解,28.9%的患者接近完全缓解,36.1%的患者部分缓解,18.1%的患者无反应。研究发现,上直肠肿瘤与中、下直肠肿瘤相比反应较差,女性与男性相比反应较差。结论:尽管新辅助放化疗仍然是局部晚期直肠癌的标准治疗方法,但其在上直肠肿瘤中的益处需要在更大规模的研究中得到验证。
{"title":"Evaluation Of Pathological Response And Its Predictors In Carcinoma Rectum Following Neoadjuvant Chemoradiation.","authors":"Shoaib Nawaz,&nbsp;Sangeetha K Nayanar,&nbsp;Nabeel Yahiya","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Neoadjuvant chemoradiation followed by surgery is the standard of care in locally advanced rectal tumors. Better pathologic response after chemoradiation is associated with better outcomes. Pathologic response may depend on various, patient and tumor related factors. The aim of our study was to assess the pathological response using a modified Ryan scoring system and to study various factors which influence the response.</p><p><strong>Materials and methods: </strong>This is a retrospective study carried out at a tertiary cancer centre in India. Patient details and histopathology reports of rectal cancer patients who took neoadjuvant chemoradiation from January 2016 to December 2018 were analyzed. Demographic details, pathological response assessed by modified Ryans tumor regression grade (TRG) score and various factors which influence the pathological response were studied. Those with TRG score 0 (complete response) and1(near complete response) were grouped together as good responders and those with score 3 (partial response) and 4 (poor or no response) as poor responders. Univariate and multivariate analyses were performed using logistic regression to determine factors which influence pathologic response.</p><p><strong>Results: </strong>There were a total of 83 patients. Males and females were equally distributed. 43.4%(n=36) of patients had lower rectal tumors,32.5%(n=27) had midrectal tumors and 24.1%(n=20) had upper rectal tumors. 46% of patients were good responders which includes complete responders ,17% (n=14) and those with a near complete response,29% (n=24). 54% of patients were poor responders,which includes those with incomplete response,36% (n=34) and with no or poor response,18% (n=15). Among the upper rectal tumors, only 20% had good response and among the mid and lower rectal tumors 54% had good response.(p value 0.02).63% of males were good responders in comparison to 37% among females (p value 0.05).</p><p><strong>Discussion: </strong>Response to neoadjuvant chemoradiation with capecitabine in locally advanced rectal tumors in our institute is similar to the literature data with a complete response in 16.9%, near complete response in 28.9% partial response in 36.1% and no response in 18.1% of patients, according to modified Ryan score. It was found that upper rectal tumors had a poorer response when compared to mid and lower tumors and females had a poorer response compared to males.</p><p><strong>Conclusion: </strong>Even though neoadjuvant chemoradiation remains the standard of care in locally advanced rectal carcinomas, its benefit in upper rectal tumors needs to be validated in larger studies.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"17-22"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39912923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Study of the Effect of Licorice Muco-adhesive Film on Radiotherapy Induced Oral Mucositis, A Randomized Controlled Clinical Trial. 甘草黏附膜治疗放疗所致口腔黏膜炎的临床对照研究。
Q3 Medicine Pub Date : 2021-09-01
Fahimeh Pakravan, Niloofar Heydari Salehabad, Fatemeh Karimi, Mehdi Nasr Isfahani

Background: Oral mucositis is a common complication induced by radiation in head and neck cancer patients. OM can cause pain, dysphagia, dehydration and impaired quality of life. The main objective of this study was to assess the effectiveness of licorice mucoadhesive film on symptoms of head and neck radiotherapy-induced mucositis.

Methods: sixty head and neck cancer patients who have been scheduled to undergo radiotherapy were randomly assigned to receive radiotherapy plus licorice mucoadhesive film (30) or radiotherapy plus placebo mucoadhesive film. In this double blinded randomized clinical trial, oral mucositis was estimated by world health organization scales, a quantitative scale, and symptoms were evaluated by visual analog scale.

Results: The results showed a meaningful difference in pain score between two groups in third and fourth weeks (P-value <0.05). Also, there was a significant difference in scale of mucositis between the two groups in weeks 3 and 4 (P-value <0.05). However, there were no meaningful differences with regard to pain and scale of mucositis in weeks 0, 1, 2. (P-value>0.05).

Conclusion: This study showed that licorice mucoadhesive film can be effective in decreasing pain and level of radiation-induced mucositis and it could be administered as an alternative agent in OM management. Key words: Oral mucositis, Radiotherapy, Licorice, Mucoadhesive film, Placebo.

背景:口腔黏膜炎是头颈部肿瘤放疗后常见的并发症。OM会引起疼痛、吞咽困难、脱水和生活质量下降。本研究的主要目的是评估甘草黏附膜对头颈部放疗性黏膜炎症状的疗效。方法:将60例已定行放疗的头颈癌患者随机分为放疗加甘草粘胶膜组(30例)和放疗加安慰剂粘胶膜组(30例)。在这项双盲随机临床试验中,口腔黏膜炎采用世界卫生组织量表和定量量表进行评估,症状采用视觉模拟量表进行评估。结果:两组患者第3、4周疼痛评分差异有统计学意义(p值0.05)。结论:甘草黏合剂能有效减轻放射性粘膜炎的疼痛和程度,可作为OM治疗的替代药物。关键词:口腔黏膜炎,放疗,甘草,黏合剂,安慰剂。
{"title":"Comparative Study of the Effect of Licorice Muco-adhesive Film on Radiotherapy Induced Oral Mucositis, A Randomized Controlled Clinical Trial.","authors":"Fahimeh Pakravan,&nbsp;Niloofar Heydari Salehabad,&nbsp;Fatemeh Karimi,&nbsp;Mehdi Nasr Isfahani","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Oral mucositis is a common complication induced by radiation in head and neck cancer patients. OM can cause pain, dysphagia, dehydration and impaired quality of life. The main objective of this study was to assess the effectiveness of licorice mucoadhesive film on symptoms of head and neck radiotherapy-induced mucositis.</p><p><strong>Methods: </strong>sixty head and neck cancer patients who have been scheduled to undergo radiotherapy were randomly assigned to receive radiotherapy plus licorice mucoadhesive film (30) or radiotherapy plus placebo mucoadhesive film. In this double blinded randomized clinical trial, oral mucositis was estimated by world health organization scales, a quantitative scale, and symptoms were evaluated by visual analog scale.</p><p><strong>Results: </strong>The results showed a meaningful difference in pain score between two groups in third and fourth weeks (P-value <0.05). Also, there was a significant difference in scale of mucositis between the two groups in weeks 3 and 4 (P-value <0.05). However, there were no meaningful differences with regard to pain and scale of mucositis in weeks 0, 1, 2. (P-value>0.05).</p><p><strong>Conclusion: </strong>This study showed that licorice mucoadhesive film can be effective in decreasing pain and level of radiation-induced mucositis and it could be administered as an alternative agent in OM management. Key words: Oral mucositis, Radiotherapy, Licorice, Mucoadhesive film, Placebo.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"42-47"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39912927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infratemporal Fossa Synovial Sarcoma In A 3-Month-Old Infant: An Extremely Rare Tumour In Infancy. 3个月婴儿颞下窝滑膜肉瘤:一种极为罕见的婴儿肿瘤。
Q3 Medicine Pub Date : 2021-09-01 DOI: 10.15557/pimr.2021.0057
Nur Adillah Lamry, K. Misron, T. M. I. Tengku Kamalden, S. Mohamad
Soft tissue sarcoma, especially synovial sarcoma is extremely rare in infancy. Only few cases were reported, and challenges lies in disease eradication and subsequent adjuvant therapy. Due to particularly small size of head and neck region with important structures are in intimate location with each other, surgical resection is very challenging, in order to ensure total disease resection as well as maintaining function and cosmetic outcome post-operatively. We present an uncommon case of synovial sarcoma of infratemporal fossa diagnosed in a 3-month-old infant. Due to extreme age, it poses difficulty to the managing team with regards to surgical intervention and oncological regimes. Keywords : Synovial sarcoma; infratemporal fossa; infant.
软组织肉瘤,尤其是滑膜肉瘤在婴儿期极为罕见。只有少数病例报告,挑战在于疾病的根除和随后的辅助治疗。由于头颈部区域体积特别小,重要结构相互靠近,手术切除是非常具有挑战性的,既要保证疾病的完全切除,又要保证术后功能和美观。我们报告一例罕见的颞下窝滑膜肉瘤的诊断在一个3个月大的婴儿。由于极端年龄,它给管理团队在手术干预和肿瘤治疗方面带来了困难。关键词:滑膜肉瘤;颞颥骨下的窝;婴儿。
{"title":"Infratemporal Fossa Synovial Sarcoma In A 3-Month-Old Infant: An Extremely Rare Tumour In Infancy.","authors":"Nur Adillah Lamry, K. Misron, T. M. I. Tengku Kamalden, S. Mohamad","doi":"10.15557/pimr.2021.0057","DOIUrl":"https://doi.org/10.15557/pimr.2021.0057","url":null,"abstract":"Soft tissue sarcoma, especially synovial sarcoma is extremely rare in infancy. Only few cases were reported, and challenges lies in disease eradication and subsequent adjuvant therapy. Due to particularly small size of head and neck region with important structures are in intimate location with each other, surgical resection is very challenging, in order to ensure total disease resection as well as maintaining function and cosmetic outcome post-operatively. We present an uncommon case of synovial sarcoma of infratemporal fossa diagnosed in a 3-month-old infant. Due to extreme age, it poses difficulty to the managing team with regards to surgical intervention and oncological regimes. Keywords : Synovial sarcoma; infratemporal fossa; infant.","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37 1","pages":"91-94"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44948312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infratemporal Fossa Synovial Sarcoma In A 3-Month-Old Infant: An Extremely Rare Tumour In Infancy. 3个月婴儿颞下窝滑膜肉瘤:一种极为罕见的婴儿肿瘤。
Q3 Medicine Pub Date : 2021-09-01
Nur Adillah Lamry, Khairunnisak Misron, Tengku Mohamed Izam Tengku Kamalden, Sakinah Mohamad

Soft tissue sarcoma, especially synovial sarcoma is extremely rare in infancy. Only few cases were reported, and challenges lies in disease eradication and subsequent adjuvant therapy. Due to particularly small size of head and neck region with important structures are in intimate location with each other, surgical resection is very challenging, in order to ensure total disease resection as well as maintaining function and cosmetic outcome post-operatively. We present an uncommon case of synovial sarcoma of infratemporal fossa diagnosed in a 3-month-old infant. Due to extreme age, it poses difficulty to the managing team with regards to surgical intervention and oncological regimes. Keywords : Synovial sarcoma; infratemporal fossa; infant.

软组织肉瘤,尤其是滑膜肉瘤在婴儿期极为罕见。只有少数病例报告,挑战在于疾病的根除和随后的辅助治疗。由于头颈部区域体积特别小,重要结构相互靠近,手术切除是非常具有挑战性的,既要保证疾病的完全切除,又要保证术后功能和美观。我们报告一例罕见的颞下窝滑膜肉瘤的诊断在一个3个月大的婴儿。由于极端年龄,它给管理团队在手术干预和肿瘤治疗方面带来了困难。关键词:滑膜肉瘤;颞颥骨下的窝;婴儿。
{"title":"Infratemporal Fossa Synovial Sarcoma In A 3-Month-Old Infant: An Extremely Rare Tumour In Infancy.","authors":"Nur Adillah Lamry,&nbsp;Khairunnisak Misron,&nbsp;Tengku Mohamed Izam Tengku Kamalden,&nbsp;Sakinah Mohamad","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Soft tissue sarcoma, especially synovial sarcoma is extremely rare in infancy. Only few cases were reported, and challenges lies in disease eradication and subsequent adjuvant therapy. Due to particularly small size of head and neck region with important structures are in intimate location with each other, surgical resection is very challenging, in order to ensure total disease resection as well as maintaining function and cosmetic outcome post-operatively. We present an uncommon case of synovial sarcoma of infratemporal fossa diagnosed in a 3-month-old infant. Due to extreme age, it poses difficulty to the managing team with regards to surgical intervention and oncological regimes. Keywords : Synovial sarcoma; infratemporal fossa; infant.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"91-94"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation Of Intraoperative Touch Imprint Cytology Of Axillary Sentinel Lymph Node Accuracy In Comparison To The Permanent Histology Diagnosis. A prospective study Of 25 Invasive Breast Cancers. 术中触摸印迹细胞学对腋窝前哨淋巴结与永久组织学诊断的准确性评价。25例浸润性乳腺癌的前瞻性研究
Q3 Medicine Pub Date : 2021-09-01
Mohammed S Saeed, Taha Al-Lawati, Fatma Al Lawati, Raymond N Elias

Background: Intraoperative evaluation of axillary sentinel lymph node (SLN) in patients with breast carcinoma reduces the need of re-operations for axillary lymph node dissection. Various methods such as touch imprintcytology (TIC) and frozen section histology (FS) have been used to determine the SLN status intra-operatively. The sensitivity of intraoperative TIC examination on SLN is not consistent and varies in different studies. The aim of this study was to determine the specificity and sensitivity of TIC, and its feasibility in clinical use.

Methods: A prospective study was conducted on 24 female and 1 male patients with histologically proven breast carcinoma and an at most clinical stage of cT2N0, between March 2017 and 2020. Axillary lymph nodes were not detected/palpable on physical examination. The patient underwent breast-conserving surgery i.e. quadrantectomy with sentinel lymph node biopsy. The intact lymph nodes were sent to histopathology laboratory for intraoperative TIC. The nodes were bisected, touch smears made and stained using the H&E and may Grunwald - Giemsa methods. The remaining tissue was processed in formalin fixed paraffin-embedded blocks and the slides were stained with H&E.

Results: In the three- year period (2017-2020), sentinel lymph node intraoperative touch imprint cytology was performed on 25 patients' lymph nodes with primary breast cancer and clinically negative axillary lymph nodes in Muscat Private Hospital, Muscat, Oman. The average age of the patients was 54.69 year. SLN- TIC revealed 88.9% sensitivity, 93.75% specificity, 11.1% false negative rate and 6.25% false positive with an overall accuracy 92%.

Conclusion: Touch imprint cytology has high sensitivity and specificity with an accepted accuracy. Intraoperative TIC is practical, time-efficient, and cost-effective procedure requiring minimal tissue preparation for SLN evaluation especially in clinical practice where FS is unavailable. Intraoperative touch imprint cytology can detect macrometastasis and micrometastasis to a lesser extent. Key words: breast carcinoma, sentinel node biopsy, intraoperative diagnosis, touch imprint cytology, micrometastasis.

背景:术中评估乳腺癌患者腋窝前哨淋巴结(SLN)可减少再次手术进行腋窝淋巴结清扫的需要。各种方法,如触摸印迹细胞学(TIC)和冷冻切片组织学(FS)已被用于确定术中SLN的状态。术中TIC检查对SLN的敏感性不一致,在不同的研究中存在差异。本研究的目的是确定TIC的特异性和敏感性,以及其在临床应用的可行性。方法:在2017年3月至2020年3月期间,对24名经组织学证实的乳腺癌患者和1名男性患者进行前瞻性研究,这些患者的临床分期为cT2N0。体格检查未见腋窝淋巴结。患者接受保乳手术,即四象限切除术和前哨淋巴结活检。术中完整淋巴结送组织病理学实验室进行TIC检查。对淋巴结进行等分,用H&E和可能的Grunwald - Giemsa方法制作和染色触摸涂片。剩余组织在福尔马林固定石蜡包埋块中处理,载玻片进行H&E染色。结果:2017-2020年3年间,在阿曼马斯喀特马斯喀特私立医院对25例原发性乳腺癌伴临床阴性腋窝淋巴结患者行前哨淋巴结术中触印细胞学检查。患者平均年龄54.69岁。SLN- TIC的敏感性为88.9%,特异性为93.75%,假阴性率为11.1%,假阳性率为6.25%,总体准确率为92%。结论:触觉印迹细胞学检测具有较高的灵敏度和特异性,准确度可接受。术中TIC是一种实用、省时、经济的方法,需要最少的组织准备来进行SLN评估,特别是在临床实践中,无法获得FS。术中触摸印迹细胞学对大转移和微转移的检测程度较低。关键词:乳腺癌,前哨淋巴结活检,术中诊断,触摸印迹细胞学,微转移。
{"title":"Evaluation Of Intraoperative Touch Imprint Cytology Of Axillary Sentinel Lymph Node Accuracy In Comparison To The Permanent Histology Diagnosis. A prospective study Of 25 Invasive Breast Cancers.","authors":"Mohammed S Saeed,&nbsp;Taha Al-Lawati,&nbsp;Fatma Al Lawati,&nbsp;Raymond N Elias","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Intraoperative evaluation of axillary sentinel lymph node (SLN) in patients with breast carcinoma reduces the need of re-operations for axillary lymph node dissection. Various methods such as touch imprintcytology (TIC) and frozen section histology (FS) have been used to determine the SLN status intra-operatively. The sensitivity of intraoperative TIC examination on SLN is not consistent and varies in different studies. The aim of this study was to determine the specificity and sensitivity of TIC, and its feasibility in clinical use.</p><p><strong>Methods: </strong>A prospective study was conducted on 24 female and 1 male patients with histologically proven breast carcinoma and an at most clinical stage of cT2N0, between March 2017 and 2020. Axillary lymph nodes were not detected/palpable on physical examination. The patient underwent breast-conserving surgery i.e. quadrantectomy with sentinel lymph node biopsy. The intact lymph nodes were sent to histopathology laboratory for intraoperative TIC. The nodes were bisected, touch smears made and stained using the H&E and may Grunwald - Giemsa methods. The remaining tissue was processed in formalin fixed paraffin-embedded blocks and the slides were stained with H&E.</p><p><strong>Results: </strong>In the three- year period (2017-2020), sentinel lymph node intraoperative touch imprint cytology was performed on 25 patients' lymph nodes with primary breast cancer and clinically negative axillary lymph nodes in Muscat Private Hospital, Muscat, Oman. The average age of the patients was 54.69 year. SLN- TIC revealed 88.9% sensitivity, 93.75% specificity, 11.1% false negative rate and 6.25% false positive with an overall accuracy 92%.</p><p><strong>Conclusion: </strong>Touch imprint cytology has high sensitivity and specificity with an accepted accuracy. Intraoperative TIC is practical, time-efficient, and cost-effective procedure requiring minimal tissue preparation for SLN evaluation especially in clinical practice where FS is unavailable. Intraoperative touch imprint cytology can detect macrometastasis and micrometastasis to a lesser extent. Key words: breast carcinoma, sentinel node biopsy, intraoperative diagnosis, touch imprint cytology, micrometastasis.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"70-78"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Grade Endometrial Stromal Sarcoma Extending to The Right Atrium. 低级别子宫内膜间质肉瘤延伸至右心房。
Q3 Medicine Pub Date : 2021-09-01
Reem M Hersi, Bashair Y AlHidri, Hatim M Al-Jifree, Mohammad Althobaiti, Hatim Q Almaghraby

Endometrial Stromal Sarcoma (ESS) are very uncommon malignant tumors that make around 0.2% of the entire uterine related malignancies. They represent the endometrial stromal cells in the proliferative stage. The annual incidence of ESS is 1-2 per million women. We present an unusual case of ESS, which originates from the uterine artery through the Inferior Vena Cava (IVC) and extends to the right atrium. A 48 years old woman presented with menorrhagia and right flank pain for seven months. Physical examination was normal except for a palpable suprapubic mass. Computed tomography (CT) showed the right gonadal vein and IVC tumoral thrombus extending into the right atrium. An echocardiogram and Transesophygeal echocardiogram revealed a large non-mobile echogenic density in the right atrium. Total abdominal hysterectomy with bilateral salpingo-oophorectomy was done. Extensive myometrial and vascular invasion was noted along with the extensive lymphovascular invasion of the uterus. Eventually, distal IVC resections were done, and there was no chance to remove the tumor because it was too attached and invaded the IVC filter. Owing to the unresectability of the tumor, the patient was assigned for palliative chemotherapy. Keywords: Endometrial Stromal Sarcoma, Right Atrium, Inferior Vena Cava, Spindle Cell Sarcoma.

子宫内膜间质肉瘤(ESS)是非常罕见的恶性肿瘤,约占整个子宫相关恶性肿瘤的0.2%。它们代表增殖阶段的子宫内膜基质细胞。ESS的年发病率为1-2 / 100万妇女。我们提出一个不寻常的ESS病例,它起源于子宫动脉通过下腔静脉(IVC)并延伸到右心房。一位48岁的女性以月经过多和右侧疼痛7个月为主诉。体格检查正常,除了可触及的耻骨上肿块。计算机断层扫描(CT)显示右侧性腺静脉和下腔静脉肿瘤血栓延伸至右心房。超声心动图和经食道超声心动图显示右心房有较大的非移动回声密度。行全腹子宫切除术并双侧输卵管卵巢切除术。广泛的子宫肌层和血管浸润,以及广泛的淋巴血管浸润子宫。最终,进行了下腔静脉远端切除术,由于肿瘤过于附着并侵入了下腔静脉滤过器,因此没有机会切除肿瘤。由于肿瘤不可切除,患者被指定进行姑息性化疗。关键词:子宫内膜间质肉瘤,右心房,下腔静脉,梭形细胞肉瘤
{"title":"Low-Grade Endometrial Stromal Sarcoma Extending to The Right Atrium.","authors":"Reem M Hersi,&nbsp;Bashair Y AlHidri,&nbsp;Hatim M Al-Jifree,&nbsp;Mohammad Althobaiti,&nbsp;Hatim Q Almaghraby","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Endometrial Stromal Sarcoma (ESS) are very uncommon malignant tumors that make around 0.2% of the entire uterine related malignancies. They represent the endometrial stromal cells in the proliferative stage. The annual incidence of ESS is 1-2 per million women. We present an unusual case of ESS, which originates from the uterine artery through the Inferior Vena Cava (IVC) and extends to the right atrium. A 48 years old woman presented with menorrhagia and right flank pain for seven months. Physical examination was normal except for a palpable suprapubic mass. Computed tomography (CT) showed the right gonadal vein and IVC tumoral thrombus extending into the right atrium. An echocardiogram and Transesophygeal echocardiogram revealed a large non-mobile echogenic density in the right atrium. Total abdominal hysterectomy with bilateral salpingo-oophorectomy was done. Extensive myometrial and vascular invasion was noted along with the extensive lymphovascular invasion of the uterus. Eventually, distal IVC resections were done, and there was no chance to remove the tumor because it was too attached and invaded the IVC filter. Owing to the unresectability of the tumor, the patient was assigned for palliative chemotherapy. Keywords: Endometrial Stromal Sarcoma, Right Atrium, Inferior Vena Cava, Spindle Cell Sarcoma.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 37","pages":"95-98"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39913373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the salivary glutaredoxin-1 levels in oral lichen planus and oral squamous cell carcinoma. 口腔扁平苔藓和口腔鳞状细胞癌患者唾液glutaredoxin-1水平的评价。
Q3 Medicine Pub Date : 2021-05-01
Maryam Amirchaghmaghi, Zohreh Dalirsani, Ala Ghazi, Leila Vazifeh Mostaan, Seyed Isaac Hashemy, Mohammad Taghi Shakeri, Fatemeh Cheshomi

Background: Glutaredoxin-1, as a component of antioxidant system, plays a crucial role in pathogenesis of some cancers and pre-malignant lesions. The aim of this study is to assess salivary levels of glutaredoxin-1 in oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC) patients compared with healthy controls.

Methods & materials: This cross-sectional study was conducted on 28 OLP patients, 20 OSCC cases, and 40 healthy subjects. Their salivary glutaredoxin-1 was assessed by the enzyme-linked immunosorbent assay (ELISA).

Results: Regarding the glutaredoxin-1 level, there was no significant difference between the three studied groups (p=0.073); however, the salivary glutaredoxin-1levels were higher in the healthy subjects than the OLP and OSCC patients. Among OSCC patients, the salivary glutaredoxin-1 levels were significantly higher in the males (p=0.03). According to glutaredoxin-1 levels, the difference between keratotic and non-keratotic OLP lesions were not significant (p=0.98). Furthermore, there was no significant difference between various clinical manifestations and grades of OSCC, (p=0.08, p=0.56, respectively).

Conclusion: Salivary glutaredoxin-1 levels were lower in OLP and OSCC patients compared to the normal volunteers; therefore the role of glutaredoxin-1 in the pathogenesis of these diseases could be proposed.

背景:Glutaredoxin-1作为抗氧化系统的一个组成部分,在一些癌症和癌前病变的发病中起着至关重要的作用。本研究的目的是评估口腔扁平苔藓(OLP)和口腔鳞状细胞癌(OSCC)患者唾液中glutaredoxin-1的水平,并与健康对照组进行比较。方法与材料:对28例OLP患者、20例OSCC患者和40例健康受试者进行横断面研究。采用酶联免疫吸附试验(ELISA)检测唾液中glutaredoxin-1的含量。结果:三组间glutaredoxin-1水平差异无统计学意义(p=0.073);而正常人唾液中glutaredocin -1水平高于OLP和OSCC患者。在OSCC患者中,男性唾液glutaredoxin-1水平显著高于男性(p=0.03)。根据glutaredoxin-1水平,角化性与非角化性OLP病变间差异无统计学意义(p=0.98)。不同临床表现和OSCC分级之间差异无统计学意义(p=0.08, p=0.56)。结论:与正常人相比,OLP和OSCC患者唾液中glutaredocin -1水平较低;因此,可以提出glutaredoxin-1在这些疾病的发病机制中的作用。
{"title":"Evaluation of the salivary glutaredoxin-1 levels in oral lichen planus and oral squamous cell carcinoma.","authors":"Maryam Amirchaghmaghi,&nbsp;Zohreh Dalirsani,&nbsp;Ala Ghazi,&nbsp;Leila Vazifeh Mostaan,&nbsp;Seyed Isaac Hashemy,&nbsp;Mohammad Taghi Shakeri,&nbsp;Fatemeh Cheshomi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Glutaredoxin-1, as a component of antioxidant system, plays a crucial role in pathogenesis of some cancers and pre-malignant lesions. The aim of this study is to assess salivary levels of glutaredoxin-1 in oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC) patients compared with healthy controls.</p><p><strong>Methods & materials: </strong>This cross-sectional study was conducted on 28 OLP patients, 20 OSCC cases, and 40 healthy subjects. Their salivary glutaredoxin-1 was assessed by the enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>Regarding the glutaredoxin-1 level, there was no significant difference between the three studied groups (p=0.073); however, the salivary glutaredoxin-1levels were higher in the healthy subjects than the OLP and OSCC patients. Among OSCC patients, the salivary glutaredoxin-1 levels were significantly higher in the males (p=0.03). According to glutaredoxin-1 levels, the difference between keratotic and non-keratotic OLP lesions were not significant (p=0.98). Furthermore, there was no significant difference between various clinical manifestations and grades of OSCC, (p=0.08, p=0.56, respectively).</p><p><strong>Conclusion: </strong>Salivary glutaredoxin-1 levels were lower in OLP and OSCC patients compared to the normal volunteers; therefore the role of glutaredoxin-1 in the pathogenesis of these diseases could be proposed.</p>","PeriodicalId":53633,"journal":{"name":"The gulf journal of oncology","volume":"1 36","pages":"14-20"},"PeriodicalIF":0.0,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39811991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The gulf journal of oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1